Benzinga's Top Upgrades, Downgrades For September 29, 2020

Loading...
Loading...

Upgrades

  • Argus Research upgraded the previous rating for Darden Restaurants Inc DRI from Hold to Buy. For the first quarter, Darden Restaurants had an EPS of $0.56, compared to year-ago quarter EPS of $1.38. At the moment, the stock has a 52-week-high of $124.01 and a 52-week-low of $26.15. Darden Restaurants closed at $100.53 at the end of the last trading period.
  • According to Stephens & Co., the prior rating for NCR Corp NCR was changed from Equal-Weight to Overweight. For the second quarter, NCR had an EPS of $0.27, compared to year-ago quarter EPS of $0.76. The current stock performance of NCR shows a 52-week-high of $35.87 and a 52-week-low of $10.55. Moreover, at the end of the last trading period, the closing price was at $20.03.
  • According to UBS, the prior rating for ONEOK Inc OKE was changed from Neutral to Buy. For the second quarter, ONEOK had an EPS of $0.32, compared to year-ago quarter EPS of $0.75. The current stock performance of ONEOK shows a 52-week-high of $78.48 and a 52-week-low of $12.16. Moreover, at the end of the last trading period, the closing price was at $26.00.
  • For Square Inc SQ, Wolfe Research upgraded the previous rating of Peer Perform to the current rating Outperform. In the second quarter, Square showed an EPS of $0.18, compared to $0.21 from the year-ago quarter. At the moment, the stock has a 52-week-high of $170.61 and a 52-week-low of $32.33. Square closed at $160.67 at the end of the last trading period.
  • According to Cowen & Co., the prior rating for RH RH was changed from Market Perform to Outperform. For the second quarter, RH had an EPS of $4.90, compared to year-ago quarter EPS of $3.20. The stock has a 52-week-high of $410.49 and a 52-week-low of $73.14. At the end of the last trading period, RH closed at $360.86.
  • According to Independent Research, the prior rating for JPMorgan Chase & Co JPM was changed from Hold to Buy. In the second quarter, JPMorgan Chase showed an EPS of $1.38, compared to $2.59 from the year-ago quarter. The current stock performance of JPMorgan Chase shows a 52-week-high of $141.10 and a 52-week-low of $76.91. Moreover, at the end of the last trading period, the closing price was at $96.19.
  • For Extended Stay America Inc STAY, B of A Securities upgraded the previous rating of Neutral to the current rating Buy. For the second quarter, Extended Stay America had an EPS of $0.04, compared to year-ago quarter EPS of $0.32. At the moment, the stock has a 52-week-high of $15.29 and a 52-week-low of $5.35. Extended Stay America closed at $12.31 at the end of the last trading period.
  • For Core Laboratories NV CLB, ABN Amro upgraded the previous rating of Sell to the current rating Hold. For the second quarter, Core Laboratories had an EPS of $0.14, compared to year-ago quarter EPS of $0.46. The current stock performance of Core Laboratories shows a 52-week-high of $49.22 and a 52-week-low of $6.68. Moreover, at the end of the last trading period, the closing price was at $16.00.
  • According to Goldman Sachs, the prior rating for The Estee Lauder Companies Inc EL was changed from Sell to Neutral. In the fourth quarter, Estee Lauder Cos showed an EPS of $0.53, compared to $0.64 from the year-ago quarter. At the moment, the stock has a 52-week-high of $224.23 and a 52-week-low of $137.01. Estee Lauder Cos closed at $215.78 at the end of the last trading period.
  • According to Baird, the prior rating for Franklin Electric Co Inc FELE was changed from Neutral to Outperform. Franklin Electric earned $0.54 in the second quarter, compared to $0.70 in the year-ago quarter. At the moment, the stock has a 52-week-high of $61.49 and a 52-week-low of $41.25. Franklin Electric closed at $58.43 at the end of the last trading period.
  • BMO Capital upgraded the previous rating for The Hershey Co HSY from Market Perform to Outperform. For the second quarter, Hershey had an EPS of $1.31, compared to year-ago quarter EPS of $1.31. At the moment, the stock has a 52-week-high of $161.83 and a 52-week-low of $109.88. Hershey closed at $140.31 at the end of the last trading period.
  • According to JP Morgan, the prior rating for Dominion Energy Inc D was changed from Neutral to Overweight. Dominion Energy earned $0.82 in the second quarter, compared to $0.77 in the year-ago quarter. The current stock performance of Dominion Energy shows a 52-week-high of $90.89 and a 52-week-low of $57.79. Moreover, at the end of the last trading period, the closing price was at $77.16.

 

Downgrades

  • According to MKM Partners, the prior rating for WPX Energy Inc WPX was changed from Buy to Neutral. For the second quarter, WPX Energy had an EPS of $0.12, compared to year-ago quarter EPS of $0.09. The stock has a 52-week-high of $14.43 and a 52-week-low of $1.94. At the end of the last trading period, WPX Energy closed at $5.19.
  • According to B of A Securities, the prior rating for Host Hotels & Resorts Inc HST was changed from Neutral to Underperform. In the second quarter, Host Hotels & Resorts showed an EPS of $0.26, compared to $0.53 from the year-ago quarter. At the moment, the stock has a 52-week-high of $18.90 and a 52-week-low of $7.86. Host Hotels & Resorts closed at $10.93 at the end of the last trading period.
  • According to B of A Securities, the prior rating for Choice Hotels International Inc CHH was changed from Neutral to Underperform. In the second quarter, Choice Hotels Intl showed an EPS of $0.13, compared to $1.19 from the year-ago quarter. The stock has a 52-week-high of $109.26 and a 52-week-low of $46.25. At the end of the last trading period, Choice Hotels Intl closed at $88.38.

 

Initiations

  • Craig-Hallum initiated coverage on TTM Technologies Inc TTMI with a Buy rating. The price target for TTM Technologies is set to $15.00. In the second quarter, TTM Technologies showed an EPS of $0.31, compared to $0.20 from the year-ago quarter. The stock has a 52-week-high of $16.25 and a 52-week-low of $8.06. At the end of the last trading period, TTM Technologies closed at $11.44.
  • With a current rating of Buy, B of A Securities initiated coverage on Shutterstock Inc SSTK. The price target seems to have been set at $63.00 for Shutterstock. For the second quarter, Shutterstock had an EPS of $0.62, compared to year-ago quarter EPS of $0.33. The current stock performance of Shutterstock shows a 52-week-high of $59.45 and a 52-week-low of $28.76. Moreover, at the end of the last trading period, the closing price was at $51.97.
  • With a current rating of Buy, BTIG initiated coverage on Penumbra Inc PEN. The price target seems to have been set at $233.00 for Penumbra. In the second quarter, Penumbra showed an EPS of $0.30, compared to $0.27 from the year-ago quarter. At the moment, the stock has a 52-week-high of $241.81 and a 52-week-low of $121.80. Penumbra closed at $194.38 at the end of the last trading period.
  • B of A Securities initiated coverage on Black Knight Inc BKI with a Buy rating. The price target for Black Knight is set to $97.00. Black Knight earned $0.52 in the second quarter, compared to $0.49 in the year-ago quarter. The current stock performance of Black Knight shows a 52-week-high of $87.31 and a 52-week-low of $50.01. Moreover, at the end of the last trading period, the closing price was at $85.78.
  • B of A Securities initiated coverage on Axsome Therapeutics Inc AXSM with an Underperform rating. The price target for Axsome Therapeutics is set to $66.00. For the second quarter, Axsome Therapeutics had an EPS of $0.49, compared to year-ago quarter EPS of $0.41. The stock has a 52-week-high of $109.94 and a 52-week-low of $13.64. At the end of the last trading period, Axsome Therapeutics closed at $76.46.
  • Needham initiated coverage on Stoke Therapeutics Inc STOK with a Buy rating. The price target for Stoke Therapeutics is set to $42.00. For the second quarter, Stoke Therapeutics had an EPS of $0.39, compared to year-ago quarter EPS of $1.54. The stock has a 52-week-high of $37.88 and a 52-week-low of $15.82. At the end of the last trading period, Stoke Therapeutics closed at $34.93.
  • B. Riley FBR initiated coverage on Crexendo Inc CXDO with a Buy rating. The price target for Crexendo is set to $8.00. Crexendo earned $0.04 in the second quarter, compared to $0.03 in the year-ago quarter. The current stock performance of Crexendo shows a 52-week-high of $12.78 and a 52-week-low of $3.20. Moreover, at the end of the last trading period, the closing price was at $5.84.
  • For GreenPower Motor Company Inc GP, BTIG initiated coverage, by setting the current rating at Buy. The stock has a 52-week-high of $22.75 and a 52-week-low of $9.99. At the end of the last trading period, GreenPower Motor Co closed at $10.87.
  • With a current rating of Overweight, Morgan Stanley initiated coverage on Performance Food Group Co PFGC. The price target seems to have been set at $45.00 for Performance Food Group. In the fourth quarter, Performance Food Group showed an EPS of $0.86, compared to $0.70 from the year-ago quarter. The stock has a 52-week-high of $54.49 and a 52-week-low of $7.41. At the end of the last trading period, Performance Food Group closed at $34.79.
  • With a current rating of Equal-Weight, Morgan Stanley initiated coverage on Sysco Corp SYY. The price target seems to have been set at $66.00 for Sysco. For the fourth quarter, Sysco had an EPS of $0.29, compared to year-ago quarter EPS of $1.10. At the moment, the stock has a 52-week-high of $85.98 and a 52-week-low of $26.00. Sysco closed at $61.89 at the end of the last trading period.
  • For US Foods Holding Corp USFD, Morgan Stanley initiated coverage, by setting the current rating at Equal-Weight. In the second quarter, US Foods Hldg showed an EPS of $0.25, compared to $0.64 from the year-ago quarter. The stock has a 52-week-high of $42.43 and a 52-week-low of $8.32. At the end of the last trading period, US Foods Hldg closed at $23.02.
  • With a current rating of Outperform, RBC Capital initiated coverage on Magnite Inc MGNI. The price target seems to have been set at $9.00 for Magnite. Magnite earned $0.10 in the second quarter. At the moment, the stock has a 52-week-high of $8.29 and a 52-week-low of $5.57. Magnite closed at $6.66 at the end of the last trading period.
  • With a current rating of Hold, Berenberg initiated coverage on AbbVie Inc ABBV. The price target seems to have been set at $98.00 for AbbVie. In the second quarter, AbbVie showed an EPS of $2.34, compared to $2.26 from the year-ago quarter. At the moment, the stock has a 52-week-high of $101.28 and a 52-week-low of $62.55. AbbVie closed at $87.29 at the end of the last trading period.
  • With a current rating of Buy, Berenberg initiated coverage on Bristol-Myers Squibb Company BMY. The price target seems to have been set at $73.00 for Bristol-Myers Squibb. Bristol-Myers Squibb earned $1.63 in the second quarter, compared to $1.18 in the year-ago quarter. The stock has a 52-week-high of $68.34 and a 52-week-low of $45.76. At the end of the last trading period, Bristol-Myers Squibb closed at $59.72.
  • Berenberg initiated coverage on Eli Lilly and Co LLY with a Hold rating. The price target for Eli Lilly is set to $144.00. For the second quarter, Eli Lilly had an EPS of $1.89, compared to year-ago quarter EPS of $1.50. At the moment, the stock has a 52-week-high of $170.75 and a 52-week-low of $101.36. Eli Lilly closed at $148.12 at the end of the last trading period.
  • Berenberg initiated coverage on Merck & Co Inc MRK with a Hold rating. The price target for Merck & Co is set to $88.00. For the second quarter, Merck & Co had an EPS of $1.37, compared to year-ago quarter EPS of $1.30. The current stock performance of Merck & Co shows a 52-week-high of $92.64 and a 52-week-low of $65.25. Moreover, at the end of the last trading period, the closing price was at $82.77.
  • With a current rating of Hold, Berenberg initiated coverage on Pfizer Inc PFE. The price target seems to have been set at $38.00 for Pfizer. In the second quarter, Pfizer showed an EPS of $0.78, compared to $0.80 from the year-ago quarter. The current stock performance of Pfizer shows a 52-week-high of $40.97 and a 52-week-low of $27.88. Moreover, at the end of the last trading period, the closing price was at $36.41.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Penny StocksUpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsInitiationstop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...